These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20800480)
1. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents. Liu XH; Liu HF; Shen X; Song BA; Bhadury PS; Zhu HL; Liu JX; Qi XB Bioorg Med Chem Lett; 2010 Jul; 20(14):4163-7. PubMed ID: 20538457 [TBL] [Abstract][Full Text] [Related]
5. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH; Li J; Shi JB; Song BA; Qi XB Eur J Med Chem; 2012 May; 51():294-9. PubMed ID: 22405648 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Lv PC; Li HQ; Sun J; Zhou Y; Zhu HL Bioorg Med Chem; 2010 Jul; 18(13):4606-14. PubMed ID: 20627597 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. Liu JJ; Zhang H; Sun J; Wang ZC; Yang YS; Li DD; Zhang F; Gong HB; Zhu HL Bioorg Med Chem; 2012 Oct; 20(20):6089-96. PubMed ID: 22985957 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors. Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. Li X; Lu X; Xing M; Yang XH; Zhao TT; Gong HB; Zhu HL Bioorg Med Chem Lett; 2012 Jun; 22(11):3589-93. PubMed ID: 22572580 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity. Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022 [TBL] [Abstract][Full Text] [Related]
14. Discovery of novel osthole derivatives as potential anti-breast cancer treatment. You L; An R; Wang X; Li Y Bioorg Med Chem Lett; 2010 Dec; 20(24):7426-8. PubMed ID: 21051232 [TBL] [Abstract][Full Text] [Related]
15. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents. Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Sun J; Zhu H; Yang ZM; Zhu HL Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Congiu C; Onnis V; Vesci L; Castorina M; Pisano C Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents. Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364 [TBL] [Abstract][Full Text] [Related]
20. A convenient synthesis and molecular modeling study of novel purine and pyrimidine derivatives as CDK2/cyclin A3 inhibitors. Elgazwy AS; Ismail NS; Elzahabi HS Bioorg Med Chem; 2010 Nov; 18(21):7639-50. PubMed ID: 20851615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]